|

Anti-PD-(L)1 based immunotherapy Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Standard of Care

Pipeline

Phase 2: 1

Top Sponsors

  • Memorial Sloan Kettering Cancer Center1

Indications

  • Liver Disease1
  • Non-small Cell Carcinoma1
  • NSCLC Stage IV1
  • Non-small Cell Lung Cancer Metastatic1
  • NSCLC1

Miami, Florida1 trial

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)

BAPTIST ALLIANCE - MCI (Data Collection Only)

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.